Novo Nordisk A/S (NVO)
$52.94 1.06 (2.04%)
18:30 EDT NVO Stock Quote Delayed 15 Minutes
Previous Close $52.94
Market Cap 128.08B
PE Ratio 3.37
Volume (Avg. Vol.) 3.22M
Day's Range 51.74 - 53.37
52-Week Range 41.23 - 53.55
Dividend & Yield 0.91 (1.72%)
NVO Stock Predictions, Articles, and Novo Nordisk A/S News
- From InvestorPlace
- From the Web
Don't overlook European stocks when it comes to dividends. Companies like Diageo (DEO), Novo Nordisk (NVO) and Eni (E) are stellar.
We cover the technical condition of three Big Pharma stocks, with the help of Profit Scanner, to determine where their prices may be headed.
You can't blindly buy stocks in healthcare because there are some that have some serious problems.
The overall ratings of 14 Pharmaceuticals stocks are down on Portfolio Grader this week. Each of these rates a "D" ("sell") or "F" overall ("strong sell").
This week, 9 Pharmaceuticals stocks are worse, according to the Portfolio Graderdatabase. Each of these rates a "D" ("sell") or "F" overall ("strong sell").
Why American Airlines Group Inc (AAL), Novo Nordisk A/S (ADR) (NVO) and Synchrony Financial (SYF) Are 3 of Today’s Worst Stocks
American Airlines (AAL), Novo Nordisk (NVO) and Synchrony Financial (SYF) couldn't win for losing on Tuesday. Here's the deal.
During these times it pays to stay on top of profit opportunities. Today's post is a great place to start with these latest Portfolio Grader ratings
Healthcare has been a top performing industry this year, and long-term growth in services, technological advances make these are some of the best healthcare stocks to buy for the long haul.
Healthcare stocks advanced 0.8% on Wall Street on Friday morning.
Healthcare stocks fell 1.2% on Wall Street so far on Friday.
Healthcare stocks declined on Wall Street on Monday morning, down 0.3%.
Healthcare stocks rose 2.0% on Wall Street so far on Tuesday.
Healthcare stocks advanced broadly on Wall Street on Tuesday morning, with the sector seeing an overall increase of 2.5%.
Healthcare stocks fell broadly on Wall Street on Thursday morning, with the sector seeing an overall decline of 0.2%.
Healthcare stocks rose 0.9% on Wall Street so far on Wednesday.
From Seeking Alpha
The Daily Biotech Pulse: FDA Approves Merck HIV Drugs, Five Prime CEO Quits, HTG Molecular Announces Secondary Offering
Navellier RatingsPowered by Portfolio Grader
10 Stocks Set for Monster Growth
He found Apple at $4… Oracle at $6… Amazon at $40… Now legendary growth investor Louis Navellier is giving away his latest Research Report — for FREE!
Download your FREE COPY!